{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T17:06:18Z","timestamp":1779728778397,"version":"3.53.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,25]]},"DOI":"10.7759\/cureus.109617","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:58:20Z","timestamp":1779728300000},"source":"Crossref","is-referenced-by-count":0,"title":["Early-Onset Amiodarone Pulmonary Toxicity at a Standard Maintenance Dose Masquerading as Decompensated Heart Failure: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"M. Nour","family":"Chabalout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afnan","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Inanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Alazzeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint\u00a0Committee\u00a0on\u00a0Clinical Practice Guidelines","volume":"83","author":"Joglar JA","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al.. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint\u00a0Committee\u00a0on\u00a0Clinical Practice Guidelines. J Am Coll Cardiol. 2024, 83:109-279. 10.1016\/j.jacc.2023.08.017","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.11.1312","article-title":"Prescribing amiodarone: an evidence-based review of clinical indications","volume":"298","author":"Vassallo P","year":"2007","unstructured":"Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA. 2007, 298:1312-22. 10.1001\/jama.298.11.1312","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.04.024","article-title":"Population-level incidence and risk factors for pulmonary toxicity associated with amiodarone","volume":"108","author":"Jackevicius CA","year":"2011","unstructured":"Jackevicius CA, Tom A, Essebag V, et al.. Population-level incidence and risk factors for pulmonary toxicity associated with amiodarone. Am J Cardiol. 2011, 108:705-10. 10.1016\/j.amjcard.2011.04.024","journal-title":"Am J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad726","article-title":"Amiodarone and pulmonary toxicity in atrial fibrillation: a nationwide Israeli study","volume":"45","author":"Tsaban G","year":"2024","unstructured":"Tsaban G, Ostrovsky D, Alnsasra H, et al.. Amiodarone and pulmonary toxicity in atrial fibrillation: a nationwide Israeli study. Eur Heart J. 2024, 45:379-88. 10.1093\/eurheartj\/ehad726","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2165\/11532320-000000000-00000","article-title":"Amiodarone: review of pulmonary effects and toxicity","volume":"33","author":"Papiris SA","year":"2010","unstructured":"Papiris SA, Triantafillidou C, Kolilekas L, Markoulaki D, Manali ED. Amiodarone: review of pulmonary effects and toxicity. Drug Saf. 2010, 33:539-58. 10.2165\/11532320-000000000-00000","journal-title":"Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.82.1.51","article-title":"Clinical features of amiodarone-induced pulmonary toxicity","volume":"82","author":"Dusman RE","year":"1990","unstructured":"Dusman RE, Stanton MS, Miles WM, Klein LS, Zipes DP, Fineberg NS, Heger JJ. Clinical features of amiodarone-induced pulmonary toxicity. Circulation. 1990, 82:51-9. 10.1161\/01.cir.82.1.51","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.09.1595","article-title":"Catheter ablation vs sotalol or amiodarone for ventricular tachycardia: a substudy of the VANISH2 trial","volume":"87","author":"Nery PB","year":"2026","unstructured":"Nery PB, Wells GA, Tang AS, et al.. Catheter ablation vs sotalol or amiodarone for ventricular tachycardia: a substudy of the VANISH2 trial. J Am Coll Cardiol. 2026, 87:157-68. 10.1016\/j.jacc.2025.09.1595","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(97)00220-9","article-title":"Adverse effects of low dose amiodarone: a meta-analysis","volume":"30","author":"Vorperian VR","year":"1997","unstructured":"Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol. 1997, 30:791-8. 10.1016\/s0735-1097(97)00220-9","journal-title":"J Am Coll Cardiol"},{"key":"ref9","article-title":"Pulmonary effects of low dose amiodarone: a review of the risks and recommendations for surveillance","volume":"16","author":"Sunderji R","year":"2000","unstructured":"Sunderji R, Kanji Z, Gin K. Pulmonary effects of low dose amiodarone: a review of the risks and recommendations for surveillance. Can J Cardiol. 2000, 16:1435-40.","journal-title":"Can J Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.2.646","article-title":"Pulmonary toxicity in patients receiving low-dose amiodarone","volume":"123","author":"Ott MC","year":"2003","unstructured":"Ott MC, Khoor A, Leventhal JP, Paterick TE, Burger CD. Pulmonary toxicity in patients receiving low-dose amiodarone. Chest. 2003, 123:646-51. 10.1378\/chest.123.2.646","journal-title":"Chest"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.09.008","article-title":"Meta-analysis comparing the relative risk of adverse events for amiodarone versus placebo","volume":"124","author":"Ruzieh M","year":"2019","unstructured":"Ruzieh M, Moroi MK, Aboujamous NM, Ghahramani M, Naccarelli GV, Mandrola J, Foy AJ. Meta-analysis comparing the relative risk of adverse events for amiodarone versus placebo. Am J Cardiol. 2019, 124:1889-93. 10.1016\/j.amjcard.2019.09.008","journal-title":"Am J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496123-early-onset-amiodarone-pulmonary-toxicity-at-a-standard-maintenance-dose-masquerading-as-decompensated-heart-failure-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:58:21Z","timestamp":1779728301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496123-early-onset-amiodarone-pulmonary-toxicity-at-a-standard-maintenance-dose-masquerading-as-decompensated-heart-failure-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.109617","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,25]]}}}